In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Is BPC157 Legal? WADA, FDA Status, and What You Need to Know Americans using unproven peptides sold by influencers and RFK Jr. allies What are peptides? FDA may ease restrictions on unproven health fad LiveNOW from FOX The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York